TCL Archive Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says February 20, 1998
TCL Archive Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds January 29, 2010
TCL Archive In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted March 10, 1978